TCG Crossover GP II, LLC 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:27 pm Sale | 2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS | TCG Crossover GP II, LLC | 2,470,265 5.000% | -714,920 (-22.45%) | Filing |
| 2024-02-15 4:20 pm Purchase | 2024-02-12 | 13G | Mineralys Therapeutics, Inc. MLYS | TCG Crossover GP II, LLC | 3,185,185 6.400% | 3,185,185 (New Position) | Filing |